Free Trial

SIGA Technologies (SIGA) Competitors

SIGA Technologies logo
$5.39 +0.17 (+3.26%)
Closing price 04:00 PM Eastern
Extended Trading
$5.28 -0.11 (-2.13%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA vs. VERA, IMCR, ANIP, SDGR, IDYA, AMPH, INDV, WVE, SPRY, and CALT

Should you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Vera Therapeutics (VERA), Immunocore (IMCR), ANI Pharmaceuticals (ANIP), Schrödinger (SDGR), IDEAYA Biosciences (IDYA), Amphastar Pharmaceuticals (AMPH), Indivior (INDV), Wave Life Sciences (WVE), ARS Pharmaceuticals (SPRY), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry.

SIGA Technologies vs.

Vera Therapeutics (NASDAQ:VERA) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking.

Vera Therapeutics received 36 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.13% of users gave Vera Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.

CompanyUnderperformOutperform
Vera TherapeuticsOutperform Votes
41
66.13%
Underperform Votes
21
33.87%
SIGA TechnologiesOutperform Votes
5
23.81%
Underperform Votes
16
76.19%

SIGA Technologies has a net margin of 49.33% compared to Vera Therapeutics' net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Vera Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Vera TherapeuticsN/A -50.13% -39.50%
SIGA Technologies 49.33%49.06%38.72%

Vera Therapeutics currently has a consensus target price of $64.67, suggesting a potential upside of 203.46%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Vera Therapeutics is more favorable than SIGA Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vera Therapeutics
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
3 Strong Buy rating(s)
3.20
SIGA Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

99.2% of Vera Therapeutics shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 21.7% of Vera Therapeutics shares are owned by company insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Vera Therapeutics and Vera Therapeutics both had 9 articles in the media. SIGA Technologies' average media sentiment score of 1.31 beat Vera Therapeutics' score of 0.81 indicating that SIGA Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vera Therapeutics
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SIGA Technologies
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SIGA Technologies has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vera TherapeuticsN/AN/A-$95.99M-$2.75-7.75
SIGA Technologies$138.72M2.78$68.07M$0.826.57

Vera Therapeutics has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Summary

Vera Therapeutics beats SIGA Technologies on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get SIGA Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$385.05M$6.32B$5.24B$7.07B
Dividend YieldN/A2.85%4.87%4.05%
P/E Ratio4.496.7221.1817.48
Price / Sales2.78186.92356.3585.27
Price / Cash6.3465.6738.1634.64
Price / Book1.955.576.233.79
Net Income$68.07M$141.67M$3.20B$247.10M
7 Day Performance-2.88%-11.43%-8.32%-7.32%
1 Month Performance-0.74%-14.59%-3.36%-10.19%
1 Year Performance-39.91%-18.30%2.72%-7.41%

SIGA Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
SIGA Technologies
2.5474 of 5 stars
$5.39
+3.3%
N/A-47.3%$385.05M$138.72M4.4940Options Volume
News Coverage
Positive News
Gap Down
VERA
Vera Therapeutics
2.8832 of 5 stars
$24.02
-9.8%
$64.67
+169.2%
-42.6%$1.53BN/A-9.2040News Coverage
Gap Down
High Trading Volume
IMCR
Immunocore
1.7759 of 5 stars
$29.67
+0.3%
$65.64
+121.2%
-54.4%$1.48B$310.20M-31.23320Positive News
Gap Down
ANIP
ANI Pharmaceuticals
3.4545 of 5 stars
$66.95
-1.0%
$79.75
+19.1%
+1.6%$1.46B$614.38M-121.73600Positive News
SDGR
Schrödinger
1.8428 of 5 stars
$19.74
-1.1%
$32.29
+63.6%
-24.2%$1.44B$207.54M-8.44790Gap Down
IDYA
IDEAYA Biosciences
3.1971 of 5 stars
$16.38
-3.9%
$53.58
+227.1%
-63.1%$1.43B$7M-4.9680News Coverage
Gap Down
High Trading Volume
AMPH
Amphastar Pharmaceuticals
4.0936 of 5 stars
$28.99
+2.0%
$43.50
+50.1%
-35.1%$1.38B$731.97M9.661,620
INDV
Indivior
3.3027 of 5 stars
$9.53
-0.3%
$15.00
+57.4%
-57.4%$1.31B$1.19B-27.231,164Positive News
Gap Down
WVE
Wave Life Sciences
4.5005 of 5 stars
$8.08
-6.3%
$22.60
+179.7%
+11.8%$1.24B$108.30M-7.28240High Trading Volume
SPRY
ARS Pharmaceuticals
3.0206 of 5 stars
$12.58
+0.7%
$31.00
+146.4%
+42.6%$1.23B$89.15M-24.6790Gap Down
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
$39.25
-1.9%
N/A$1.19B$1.60B-21.62180
Remove Ads

Related Companies and Tools


This page (NASDAQ:SIGA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners